Mr. Andre Larente reports

DIAGNOS ANNOUNCES CROSS-LISTING OF ITS COMMON SHARES ON THE FRANKFURT STOCK EXCHANGE

Diagnos Inc. has cross-listed its subordinate common shares on the Frankfurt Stock Exchange (FWB) under the trading symbol 4D4A. FWB is the largest of Germany's seven stock exchanges. It facilitates advanced electronic trading, settlement and information systems and enables cross-border trading for international investors.

In addition to the FWB, the corporation's subordinate common shares are also cross-listed on the OTCQB Exchange in the United States under the symbol DGNOF.

Andre Larente, president of Diagnos, stated; "By facilitating trading of the corporation's common shares in Europe, we strongly believe that cross-listing on the FWB will be beneficial to all current and future shareholders as it will contribute to increase market liquidity for the common shares of Diagnos."

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its Flaire artificial intelligence (AI) platform. Flaire allows for quick modifying and developing of applications such as CARA (computer-assisted retina analysis). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

We seek Safe Harbor.